Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment
J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy
K Sałat - Pharmacological reports, 2020 - Springer
Background Despite the increasing knowledge of the etiology of neuropathic pain, this type
of chronic pain is resistant to available analgesics in approximately 50% of patients and …
of chronic pain is resistant to available analgesics in approximately 50% of patients and …
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort …
Background There are inconsistencies in the literature regarding the prevalence and
assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored …
assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored …
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
K Sałat - Pharmacological Reports, 2020 - Springer
Background Chemotherapy-induced peripheral neuropathy (CIPN) is regarded as one of the
most common dose-limiting adverse effects of several chemotherapeutic agents, such as …
most common dose-limiting adverse effects of several chemotherapeutic agents, such as …
Chemotherapy-induced peripheral neuropathy and rehabilitation: A review
S Zhang - Seminars in oncology, 2021 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication after
chemotherapy that can damage the sensory, motor, autonomic, or cranial nerves in …
chemotherapy that can damage the sensory, motor, autonomic, or cranial nerves in …
Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice
S Acklin, M Zhang, W Du, X Zhao, M Plotkin, J Chang… - Scientific reports, 2020 - nature.com
Chemotherapy-induced peripheral neuropathy is among the most common dose-limiting
adverse effects of cancer treatment, leading to dose reduction and discontinuation of life …
adverse effects of cancer treatment, leading to dose reduction and discontinuation of life …
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings
Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common dose-limiting side
effect of several anticancer medications. CIPN may involve multiple areas of the peripheral …
effect of several anticancer medications. CIPN may involve multiple areas of the peripheral …
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
Multiple pathological mechanisms are involved in the development of chemotherapy-
induced peripheral neurotoxicity (CIPN). Recent work has provided insights into the …
induced peripheral neurotoxicity (CIPN). Recent work has provided insights into the …
Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy
PL Vollmers, C Mundhenke, N Maass… - Journal of cancer …, 2018 - Springer
Introduction Breast cancer is the most common cancer disease of women in industrialized
countries. Neurotoxic chemotherapy drugs are known to harm peripheral nerves and cause …
countries. Neurotoxic chemotherapy drugs are known to harm peripheral nerves and cause …
Taxane and epothilone‐induced peripheral neurotoxicity: from pathogenesis to treatment
Taxane‐induced peripheral neurotoxicity (TIPN) is the most common non‐hematological
side effect of taxane‐based chemotherapy, and may result in dose reductions and …
side effect of taxane‐based chemotherapy, and may result in dose reductions and …